Accelerating Control of Pertussis in England and Wales

Miller, 1992, The epidemiology of pertussis in England and Wales., Commun Dis Rep CDR Rev, 2, R152

Miller, 1999, Overview of recent clinical trials of acellular pertussis vaccines., Biologicals, 27, 79, 10.1006/biol.1999.0184

Andrews, 2010, Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom., Vaccine, 28, 7215, 10.1016/j.vaccine.2010.08.062

Health Protection Agency. Vaccination coverage statistics for children aged up to five years in the United Kingdom: July to December 2009. Health Protection Report, vol 4, no 12; 2010 Mar 26 [cited 2011 May 10]. http://www.hpa.org.uk/hpr/archives/2010/hpr1210.pdf

Fry, 2004, Laboratory diagnosis of pertussis infections: the role of PCR and serology., J Med Microbiol, 53, 519, 10.1099/jmm.0.45624-0

Fry, 2009, Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007., J Med Microbiol, 58, 1023, 10.1099/jmm.0.009878-0

Tan, 2005, Epidemiology of pertussis., Pediatr Infect Dis J, 24, S10, 10.1097/01.inf.0000160708.43944.99

Skowronski, 2002, The changing age and seasonal profile of pertussis in Canada., J Infect Dis, 185, 1448, 10.1086/340280

Quinn, 2007, Pertussis epidemiology in Australia over the decade 1995–2005: trends by region and age group., Commun Dis Intell, 31, 205

Berbers, 2009, Improving pertussis vaccination., Hum Vaccin, 5, 497, 10.4161/hv.8112

Crowcroft, 2002, Whooping cough—a continuing problem., BMJ, 324, 1537, 10.1136/bmj.324.7353.1537

Office for National Statistics. UK: mortality statistics: deaths registered in England and Wales (series DR) [cited 2011 Nov 4]. http://www.ons.gov.uk/ons/taxonomy/search/index.html?newquery=*&nscl=Causes+of+Death&nscl-orig=Causes+of+Death&sortDirection=DESCENDING&sortBy=pubdate

Van Buynder, 1999, Bordetella pertussis surveillance in England and Wales: 1995–7., Epidemiol Infect, 123, 403, 10.1017/S0950268899003052

HES Online—Hospital Episode Statistics. England [cited 2011 Nov 4]. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=202

Office for National Statistics. UK: population estimates for UK, England and Wales, Scotland and Northern Ireland—current datasets [cited 2011 May 10]. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=15106

Farrington, 1993, Estimation of vaccine effectiveness using the screening method., Int J Epidemiol, 22, 742, 10.1093/ije/22.4.742

The Information Centre. Workforce and Facilities. NHS immunisation statistics, England 2008–09 [cited 2011 Mar 17]. http://www.ic.nhs.uk/webfiles/publications/003_Health_Lifestyles/immstats2008-2009/Final_Imms_Bulletin_2008-09_Updated27Oct10.pdf

General Practice Research Database. GPRD—The General Practice Research Database [cited 2011 Mar 17]. http://www.gprd.com/home

Stowe, 2009, No evidence of an increase of bacterial and viral infections following measles, mumps and rubella vaccine., Vaccine, 27, 1422, 10.1016/j.vaccine.2008.12.038

Gustafsson, 2006, Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age., Pediatrics, 118, 978, 10.1542/peds.2005-2746

Guiso, 2007, Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life., Vaccine, 25, 1390, 10.1016/j.vaccine.2006.10.048

de Greeff, 2008, Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in the Netherlands., Pediatr Infect Dis J, 27, 218, 10.1097/INF.0b013e318161a2b9

Nardone, 2004, Sero-epidemiology of Bordetella pertussis in England and Wales., Vaccine, 22, 1314, 10.1016/j.vaccine.2003.08.039

Harnden, 2006, Whooping cough in school age children with persistent cough: a prospective cohort study in primary care., BMJ, 333, 174, 10.1136/bmj.38870.655405.AE

Tanaka, 2003, Trends in pertussis among infants in the United States, 1980–1999., JAMA, 290, 2968, 10.1001/jama.290.22.2968

Crowcroft, 2003, Severe and unrecognised: pertussis in UK infants., Arch Dis Child, 88, 802, 10.1136/adc.88.9.802

Markov, 2007, Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants., Epidemiol Infect, 135, 17, 10.1017/S0950268806006625

Crowcroft, 2002, Deaths from pertussis are underestimated in England., Arch Dis Child, 86, 336, 10.1136/adc.86.5.336

Somerville, 2007, Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras., J Paediatr Child Health, 43, 147, 10.1111/j.1440-1754.2007.01034.x

Spokes, 2010, Review of the pertussis epidemic in NSW: notifications and hospitalisations., N S W Public Health Bull, 21, 167, 10.1071/NB10031

Wendelboe, 2005, Duration of immunity against pertussis after natural infection or vaccination., Pediatr Infect Dis J, 24, S58, 10.1097/01.inf.0000160914.59160.41

Ramsay, 1993, Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods., Epidemiol Infect, 111, 41, 10.1017/S095026880005665X

Palmer, 1991, Vaccine efficacy and control measures in pertussis., Arch Dis Child, 66, 854, 10.1136/adc.66.7.854

World Health Organization, 2010, Pertussis vaccines: WHO position paper., Wkly Epidemiol Rec, 85, 385

Bisgard, 2004, Infant pertussis: who was the source?, Pediatr Infect Dis J, 23, 985, 10.1097/01.inf.0000145263.37198.2b

Zacharyczuk C. ACIP recommends expectant mothers receive pertussis vaccine. Pediatric Supersite. July 2011 [cited 2011 Jul 21]. http://www.pediatricsupersite.com/view.aspx?rid=84982

Belloni, 2003, Immunogenicity of a three-component acellular pertussis vaccine administered at birth., Pediatrics, 111, 1042, 10.1542/peds.111.5.1042

Wood, 2010, Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age., Pediatr Infect Dis J, 29, 209, 10.1097/INF.0b013e3181bc98d5

Halasa, 2008, Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine., J Pediatr, 153, 327, 10.1016/j.jpeds.2008.03.011

Knuf, 2010, Booster vaccination after neonatal priming with acellular pertussis vaccine., J Pediatr, 156, 675, 10.1016/j.jpeds.2009.12.019